Search
Dienogest
go.drugbank.com/drugs/DB09123ApprovedInvestigationalIt is primarily used as a contraceptive in combination with ethinylestradiol, or in other combination form pills approved in United States and Europe however it is not available in the US by itself. … In Europe, Australia, Malaysia, Singapore and Japan, dienogest single therapy is an approved treatment for endometriosis to alleviate painful symptoms of endometriosis and reduce endometriotic lesions
Mixtures: VELBIENNE® 20, VELBIENNE® 20Products: TAYLAFEM® COMPRIMIDO 2.0 MG, PIETRA-EDTiclopidine
go.drugbank.com/drugs/DB00208ApprovedTiclopidine is an effective inhibitor of platelet aggregation. … It is a prodrug that is metabolised to an active form, which blocks the ADP receptor that is involved in GPIIb/IIIa receptor activation leading to platelet aggregation.
Products: TICLOPIDINA EG, TACRON TABLET 250 mgEscitalopram
go.drugbank.com/drugs/DB01175ApprovedInvestigational[A185420] It is used to restore serotonergic function in the treatment of depression and anxiety. … vast majority of citalopram’s clinical activity, with some evidence suggesting that the R-enantiomer of racemic citalopram actively dampens the activity of escitalopram rather than existing simply as an
Products: Escitalopram-GN 20 mg Filmtabletten, ESCITALOPRAM EGRanitidine
go.drugbank.com/drugs/DB00863ApprovedWithdrawn[L10818,F4253] The prevalence of GERD is thought to be 10-20% in western countries. … [A176843] Ranitidine has proven to be an effective treatment for relieving uncomfortable symptoms of gastric acid associated conditions and is therefore widely used in GERD and other gastric-acid related
Products: RANITIDINA 50 MG EN SODIO CLORURO 0.7% POR 100 ML (INFUSION), RANITIDINA 50MG EN SODIO CLORURO 0.7 % POR 50 ML INFUSIONTitanium dioxide
go.drugbank.com/drugs/DB09536ApprovedTitanium dioxide, also known as titanium(IV) oxide or titania, is the naturally occurring oxide of titanium. It is used as a pigment under the names titanium white, Pigment White 6 (PW6), or CI 77891. It is typically extracted from ilmen...
Mixtures: Limited Line Edition 2018 MISSHA M Perfect Cover BB No 23, Limited Line Edition 2018 MISSHA M Perfect Cover BB No 21Categories: Compounds used in a research, industrial, or household settingLumiracoxib
go.drugbank.com/drugs/DB01283ApprovedWithdrawnOn August 11, 2007, Australia's Therapeutic Goods Administration (TGA, the Australian equivalent of the FDA) cancelled the registration of lumiracoxib in Australia due to concerns that it may cause liver … New Zealand and Canada have also followed suit in recalling the drug.
Products: PREXIGE ® 200 MG COMPRIMIDOS, PREXIGE ®100 MG COMPRIMIDOSPegfilgrastim
go.drugbank.com/drugs/DB00019ApprovedInvestigational[A187631] Due to the relatively short circulating half-life of filgrastim, a 20 kDa PEG moiety was covalently conjugated to the N-terminus of filgrastim (at the methionine residue) to develop longer-acting … [A187607] First developed by Amgen, pegfilgrastim was initially approved by the FDA in 2002 and marketed as Neulasta. It is typically administered via a subcutaneous injection.
Categories: Compounds used in a research, industrial, or household settingSynonyms: PEG-G-CSF, Pegylated G-CSFMagnesium oxide
go.drugbank.com/drugs/DB01377ApprovedInvestigationalMagnesium oxide is an inorganic compound that occurs in nature as the mineral periclase. In aqueous media combines quickly with water to form magnesium hydroxide. … It is used as an antacid and mild laxative and has many nonmedicinal uses.
Mixtures: DIMAG 365 MG TEK KULLANIMLIK TOZ ICEREN SAŞE, 20 ADET, MAGNEDUO 365 MG TEK KULLANIMLIK TOZ İÇEREN SAŞE, 20 ADETProducts: Magnesium 250 mg, MAGNEZI KALSINE 100 G TOZ, 100 GDesvenlafaxine
go.drugbank.com/drugs/DB06700ApprovedInvestigational[A261266,A261266] It was approved by the FDA in 2008 for the treatment of adults with major depressive disorder (MDD). … [L6016,A261271] MDD is a highly prevalent psychiatric disorder, with a lifetime prevalence estimate of 16% in the US alone and 12.8% in Europe.
Products: PRISTIQ® 100 MG TABLETAS DE LIBERACION PROLONGADA, PRISTIQ 100 MG EXTENDED-RELEASE TABLETSCenobamate
go.drugbank.com/drugs/DB06119ApprovedInvestigational[L10653] Cenobamate was granted FDA approval on 21 November 2019.[L10653] … Cenobamate, or YKP-3089, is an antiepileptic drug developed by SK Pharmaceuticals and used to treat partial onset seizures.
Products: XCOPRI TITRATION PACK 150 mg, 200 mg, XCOPRI MAINTENANCE PACK 150 mg, 200 mg